A-1. Pelekanou V, Notas G, Sanidas E, Tsapis A, Castanas E, Kampa M. Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR Mol Oncol. 2010 Apr;4(2):135-49.
A-2. Notas G., Pelekanou V ., Castanas E., Kampa M. Conjugated and non-conjugated androgen differentially modulate specific early gene transcription in breast cancer in a cell-specific manner. Steroids. 2009 Oct 24.
A-3. Alexaki VI, Notas G., Pelekanou V., Kampa M., Valkanou M., Theodoropoulos P., Stathopoulos E., Tsapis A., Castanas E. Adipocytes as Immune Cells: Differential Expression of TWEAK, BAFF, and APRIL and Their Receptors (Fn14, BAFF-R, TACI, and BCMA) at Different Stages of Normal and Pathological Adipose Tissue Development. J Immunol. 2009 Nov 1;183(9):5948-56.
A-4.Alexaki V.I., Charalampopoulos I, Panayotopoulou M., Kampa M., Gravanis A., Castanas E. Dehydroepiandrosterone protects human keratinocytes against apoptosis through membrane binding sites. Exp Cell Res. 2009 Aug 1;315(13):2275-83.
A-5.Pelekanou V., Kampa M., Kafousi M., Darivianaki K., Sanidas E., Tsiftsis D., Stathopoulos E., Tsapis A., Castanas E. Expression of TNF superfamily members BAFF and APRIL in breast cancer: Immunohistochemical study in 52 invasive ductal breast carcinomas BMC Cancer 2008 Mar 20;8:76.
A-6.Vassou D., Bakogeorgou E., Kampa M., Dimitriou H., Hatzoglou A., Castanas E. Modulation of B cell constitutive antibody secretion by opioids International Immunopharmacology 2008 May;8(5):634-44.
A-7.Litos I., Emmanouilidou E., Glynou K., Laios E., Ioannou P., Christopoulos T., Kampa M., Castanas E., Achille Gravanis A. Rapid Genotyping of CYP2D6, CYP2C19 and TPMT Polymorphisms by Primer Extension Reaction in a Dipstick Format. Anal Bioanal Chem. 2007 Nov; 389;(6):1849-1857.
A-8.Kampa M., Pelekanou V., Castanas E. Membrane-initiated steroid action in breast and prostate cancer. Steroids 2008 Oct;73(9-10):953-60.
A-9.Pelekanou V., Kampa M., Kafousi M., Dambaki K., Darivianaki K., Vrekousis T., Sanidas E., Tsiftsis D., Stathopoulos E., Castanas E. Erythropoietin and its receptor in breast cancer: correlation with steroid receptors and outcome. Cancer Epidemiol Biomarkers Prev. 2007, 16(10):1-8.
A-10.Notas G., Kampa M., Nifli AP., Xidakis C., Papasava D., Thermos K., Kouroumalis E., Castanas E., The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors. Eur J Pharmacol. 2007 555:1-7.
A-11.Kampa M., Nifli AP., Notas G., Castanas E. Polyphenols and cancer cell growth. Rev Physiol Biochem Pharmacol. 2007; 159:79-113.
A-12.Kampa M., Castanas E. Human health effects of air pollution. Environ Pollut. 2007 Jul 21 1-6. PMID: 17646040.
A-13.Notas G., Nifli AP., Kampa M., Vercauteren J., Kouroumalis E Castanas E. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular arcinoma cells, by inducing cell cycle arrest, and NOS activation.Biochim Biophys Acta. 2006 Nov;1760(11):1657-66.
A-14.Kampa M., Kogia C., Theodoropoulos PA., Anezinis P., Charalampopoulos I., Papakonstanti EA., Stathopoulos EN., Hatzoglou A., Stournaras C., Gravanis A., Castanas E. Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther. 2006 May;5(5):1342-51.
A-15.Melissas J., Malliaraki N., Papadakis JA., Taflampas P., Kampa M., Castanas E. Plasma antioxidant capacity in morbidly obese patients before and after weight loss. Obes Surg. 2006 Mar;16(3):314-20.
A-16.Kampa M., Castanas E. Membrane steroid receptor signaling in normal and neoplastic cells. Mol Cell Endocrinol. 2006 Feb 26;246(1-2):76-82.
A-17.Dimitriou H., Bakogeorgou., Kampa M., Notas G., Stiakaki E., Kouroumalis E., Kalmanti M., Castanas E. kappa-opioids induce a reversible inhibition of CFU-GM from CD133(+) cord blood cells. Cytotherapy. 2006;8(4):367-74.
A-18.Alexaki VI., Dermitzaki E., Charalampopoulos I., Kampa M., Nifli AP., Gravanis A., Margioris A., Castanas E. Neuronal differentiation of PC12 cells abolishes the expression of membrane androgen receptors. Exp Cell Res. 2006 Sep 10;312(15):2745-56.
A-19.Alexaki VI., Charalampopoulos I., Kampa M., Nifli AP., Hatzoglou A., Gravanis A., Castanas E. Activation of membrane estrogen receptors induce pro-survival kinases. J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):97-110.
A-20.Notas G., Maliaraki N., Kampa M., Dimoulios F., Matrella E., Hatzidakis A., Castanas E., Kouroumalis E. Patients with primary biliary cirrhosis have increased serum total antoxidant capacity measured with the crocin bleaching assay. World J. Gastroenterol. Jul 21; 11(27):4194-8, 2005.
A-21.Nifli AP., Bosson-Kouame A., Papadopoulou N., Kogia C., Kampa M., Castagnino C., Stournaras C., Vercauteren J., Castanas E. Monomeric and oligomeric flavanols are agonists of membrane androgen receptors. Exp. Cell. Res. 309, 329-339, 2005.
A-22.Nifli AP., Kampa M., Alexaki VI., Notas G., Castanas E. Polyphenol interaction with the T47D human breast cancer cell line. J. Dairy Res 72, 44-50, 2005.
A-23.Kampa M., Nifli AP, Charalampopoulos I., Alexaki VI., Theodoropoulos PA., Stathopoulos EN., Gravanis A., Castanas E. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp. Cell. Res. Jul 1; 307(1):41-51, 2005.
A-24.Hatzoglou A., Kampa M., Kogia C., Charalampopoulos I., Theodoropoulos PA., Anezinis P., Dambaki C., Papakonstanti EA., Stathopoulos EN., Stournaras C., Gravanis A., Castanas E. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J. Clin. Endocrinol. Metab. 90, 893-903, 2005.
A-25.Dambaki C., Kogia Ch., Kampa M., Darivianaki K., Nomikos M., Theodoropoulos P., Anezinis P., Castanas E., Stathopoulos EN. Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections. BMC Cancer. 2005 Nov 17;5:148.
A-26.Hatzoglou A., Kampa M., Castanas E. Opioid-somatostatin interactions in regulating cancer cell growth. Front. Biosci. 10, 244-256, 2005.
A-27.Notas G., Kolios G., Mastrodimou N., Kampa M., Vasilaki A., Xidakis C., Castanas E., Thermos K., Kouroumalis E. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of Somatostatin receptors. J. Hepatol 40, 792-798, 2005.
